Ardent Health director granted 14,231 RSUs

Ardent Health, Inc. director Peter J. Bulgarelli reported receiving a grant of 14,231 shares of common stock in the form of restricted stock units at no cash exercise price.

Rhea-AI Filing Summary

Ardent Health, Inc. director Peter J. Bulgarelli reported receiving a grant of 14,231 shares of common stock in the form of restricted stock units at no cash exercise price. Following this award, he holds 14,231 shares directly. The units vest in full on the first anniversary of April 1, 2026, conditioned on his continued service with the company through that vesting date.

Insider Trade Summary

Grant/Award: 14,231 shares

Grant/Award 1 txn

Insider Bulgarelli Peter J.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	14,231	$0.00	$0.00

Holdings After Transaction: Common Stock — 14,231 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date.

Key Figures

RSUs granted: 14,231 shares Reported grant price: $0.00 per share Shares held after grant: 14,231 shares

3 metrics

RSUs granted 14,231 shares Restricted stock units award to director on April 1, 2026

Reported grant price $0.00 per share Equity award, not open-market purchase

Shares held after grant 14,231 shares Total direct holdings following transaction

Key Terms

restricted stock units, vest, continued service

3 terms

restricted stock units financial

"Represents restricted stock units that vest in full on the first anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest financial

"restricted stock units that vest in full on the first anniversary"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

continued service financial

"subject to the Reporting Person's continued service with the Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ardent Health (ARDT) report for Peter J. Bulgarelli?

Ardent Health director Peter J. Bulgarelli reported acquiring 14,231 restricted stock units of common stock. The award was recorded at a price of $0.00 per share and represents equity compensation rather than an open-market purchase or sale.

How many Ardent Health (ARDT) shares does Peter J. Bulgarelli hold after this Form 4?

After the reported grant, Peter J. Bulgarelli holds 14,231 shares of Ardent Health common stock directly. This total equals the number of restricted stock units awarded in the transaction, indicating this filing reflects his current reported direct holdings.

What type of equity award did Ardent Health (ARDT) grant to its director?

Ardent Health granted Peter J. Bulgarelli restricted stock units representing 14,231 shares of common stock. Restricted stock units are equity awards that convert into shares upon vesting, typically used as part of long-term director or executive compensation programs.

When do Peter J. Bulgarelli’s Ardent Health (ARDT) restricted stock units vest?

The restricted stock units vest in full on the first anniversary of April 1, 2026. Vesting is subject to Bulgarelli’s continued service with Ardent Health through that vesting date, aligning the award with ongoing board service.

Did Peter J. Bulgarelli buy or sell Ardent Health (ARDT) shares in the market?

The Form 4 shows a grant of 14,231 restricted stock units at a reported price of $0.00 per share. This is a compensation-related award, not an open-market purchase or sale, so no cash-based market trade is disclosed in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:51 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bulgarelli Peter J.

(Last) (First) (Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A		14,231(1)	A	$0	14,231	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date.

Remarks:

	/s/ Stephen C. Petrovich, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)